{"id":6662,"date":"2017-08-13T07:38:59","date_gmt":"2017-08-13T07:38:59","guid":{"rendered":"https:\/\/andromedichyperthermia.com\/andromedic-esho-2014\/"},"modified":"2026-02-17T10:36:04","modified_gmt":"2026-02-17T10:36:04","slug":"andromedic-esho-2014","status":"publish","type":"page","link":"https:\/\/andromedichyperthermia.com\/es\/andromedic-esho-2014\/","title":{"rendered":"Sociedad Europea de Oncolog\u00eda Hipert\u00e9rmica ESHO 2014 &#8211; ensayos cl\u00ednicos hipertermia Andromedic"},"content":{"rendered":"<p><script type=\"application\/ld+json\">\n{\n  \"@context\": \"https:\/\/schema.org\",\n  \"@graph\": [\n    {\n      \"@type\": \"MedicalWebPage\",\n      \"@id\": \"https:\/\/andromedichyperthermia.com\/es\/andromedic-esho-2014\/#webpage\",\n      \"url\": \"https:\/\/andromedichyperthermia.com\/es\/andromedic-esho-2014\/\",\n      \"name\": \"Ensayos cl\u00ednicos con Andromedic HyDeep 600 WM - Congreso ESHO\",\n      \"description\": \"Datos de estudios cl\u00ednicos sobre HyDeep 600 WM para el c\u00e1ncer de cuello uterino y estudios de viabilidad multic\u00e9ntricos presentados en el congreso ESHO.\",\n      \"inLanguage\": \"es-ES\",\n      \"isPartOf\": { \"@id\": \"https:\/\/andromedichyperthermia.com\/#website\" },\n      \"mainEntity\": { \"@id\": \"https:\/\/andromedichyperthermia.com\/#hydeep-600wm\" },\n      \"about\": [\n        {\n          \"@type\": \"MedicalStudy\",\n          \"name\": \"Estudio LACC sobre carcinoma cervical\",\n          \"description\": \"Estudio en 8 pacientes que demuestra un 100% de control local mediante el uso del sistema HyDeep 600 WM y braquiterapia HDR.\",\n          \"studySubject\": { \"@type\": \"MedicalCondition\", \"name\": \"C\u00e1ncer de cuello uterino\" }\n        },\n        {\n          \"@type\": \"MedicalStudy\",\n          \"name\": \"Estudio de casos y controles en Espa\u00f1a\",\n          \"description\": \"Estudio de viabilidad a gran escala con 293 pacientes que abarca 9 localizaciones tumorales.\",\n          \"sampleSize\": 293,\n          \"studyStatus\": \"Published\"\n        }\n      ],\n      \"mentions\": [\n        { \"@id\": \"https:\/\/andromedichyperthermia.com\/hyperthermia-doctor-salvatore-conte\/\" },\n        { \"@id\": \"https:\/\/andromedichyperthermia.com\/#organization\" }\n      ]\n    },\n    {\n      \"@type\": [\"Product\", \"MedicalDevice\"],\n      \"@id\": \"https:\/\/andromedichyperthermia.com\/#hydeep-600wm\",\n      \"name\": \"HyDeep 600WM\",\n      \"brand\": { \"@type\": \"Brand\", \"name\": \"Andromedic\" },\n      \"image\": \"https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/HyDeep-600WM-Andromedic.jpg\",\n      \"description\": \"Sistema de hipertermia oncol\u00f3gica avanzada \/ dispositivo de hipertermia local profunda \/ dispositivo de hipertermia RF modulada (13,56 MHz).\",\n      \"offers\": {\n        \"@type\": \"Offer\",\n        \"price\": \"0\",\n        \"priceCurrency\": \"EUR\",\n        \"availability\": \"https:\/\/schema.org\/InStock\",\n        \"url\": \"https:\/\/andromedichyperthermia.com\/es\/contact\/\",\n        \"priceSpecification\": {\n          \"@type\": \"PriceSpecification\",\n          \"description\": \"Precio bajo petici\u00f3n\"\n        }\n      },\n      \"review\": {\n        \"@type\": \"Review\",\n        \"author\": { \"@type\": \"Person\", \"name\": \"Dr. med. Veronica Iatan\" },\n        \"reviewRating\": { \"@type\": \"Rating\", \"ratingValue\": \"5\", \"bestRating\": \"5\" },\n        \"reviewBody\": \"Tecnolog\u00eda de vanguardia para hipertermia profunda con protocolos validados cl\u00ednicamente.\"\n      }\n    },\n    {\n      \"@type\": \"MedicalOrganization\",\n      \"@id\": \"https:\/\/andromedichyperthermia.com\/#organization\",\n      \"name\": \"Andromedic Srl\"\n    }\n  ]\n}\n<\/script><\/p>\n<div style=\"line-height: 1.6; color: #333; max-width: 1100px; margin: auto; font-family: 'Segoe UI', Helvetica, sans-serif; background-color: #fff; padding: 20px;\">\n<header style=\"border-bottom: 4px solid #1a2a6c; padding-bottom: 25px; margin-bottom: 40px; text-align: center;\">\n<h1 style=\"color: #1a2a6c; font-size: 28px; font-weight: 800; text-transform: uppercase; margin-bottom: 10px;\">Sociedad Europea de Oncolog\u00eda Hipert\u00e9rmica: ESHO 2014<\/h1>\n<h2 style=\"color: #b21f1f; font-size: 20px; font-weight: 600;\">Intervenci\u00f3n Andromedic \u2013 Dr. Salvatore Conte<\/h2>\n<p style=\"font-size: 16px; max-width: 850px; margin: 15px auto; color: #555;\">En el congreso <a href=\"http:\/\/esho.info\" target=\"_blank\" rel=\"noopener\">ESHO 2014<\/a>, el <a href=\"https:\/\/andromedichyperthermia.com\/hyperthermia-doctor-salvatore-conte\/\"><strong>Dr. Salvatore Conte<\/strong><\/a> anunci\u00f3 un hito importante para el equipo de hipertermia de Andromedic: la fabricaci\u00f3n y entrega exitosa de 25 <a href=\"https:\/\/andromedichyperthermia.com\/es\/dispositivo-hipertermia-oncologica\/\">dispositivos de hipertermia local profunda <strong>HyDeep 600WM<\/strong><\/a> en solo 18 meses, con 40 unidades adicionales destinadas al mercado de la India.<\/p>\n<\/header>\n<div style=\"margin-bottom: 50px; border-radius: 15px; overflow: hidden; box-shadow: 0 10px 25px rgba(0,0,0,0.2);\">\n<p><iframe loading=\"lazy\" title=\"intervento Andromedic   Esho 20014\" width=\"640\" height=\"360\" src=\"https:\/\/www.youtube.com\/embed\/fgMdXxoJ1cI?feature=oembed\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share\" referrerpolicy=\"strict-origin-when-cross-origin\" allowfullscreen><\/iframe><\/p>\n<\/div>\n<h2 style=\"text-align: center; color: #1a2a6c; margin-bottom: 30px; text-transform: uppercase;\">Estudios Cl\u00ednicos Presentados: HyDeep 600WM Hipertermia Oncol\u00f3gica Avanzada<\/h2>\n<section style=\"margin-bottom: 50px; border: 1px solid #e1e8ed; border-radius: 15px; overflow: hidden; box-shadow: 0 5px 15px rgba(0,0,0,0.05);\">\n<div style=\"background: #1a2a6c; color: #fff; padding: 20px;\">\n<h3 style=\"margin: 0; font-size: 19px;\">1. Quimiorradioterapia + Hipertermia + Braquiterapia HDR para LACC<\/h3>\n<\/div>\n<div style=\"padding: 30px; background: #f9f9f9;\">\n<p><strong>OBJETIVOS:<\/strong> Investigar los resultados de la combinaci\u00f3n de cisplatino semanal e hipertermia local profunda con IMRT seguida de BRT para el carcinoma de cuello uterino localmente avanzado (LACC).<\/p>\n<div style=\"background: #fff; padding: 20px; border-radius: 10px; margin: 20px 0; border-left: 5px solid #b21f1f;\">\n<p><strong>MATERIALES Y M\u00c9TODOS:<\/strong><\/p>\n<ul style=\"margin-top: 10px; font-size: 15px;\">\n<li><strong>Grupo de pacientes:<\/strong> 8 pacientes (3 estadio IIB, 1 IIIB, 2 NEI, 3 LRCC).<\/li>\n<li><strong>Protocolo:<\/strong> 50.4 Gy en los ganglios linf\u00e1ticos p\u00e9lvicos con SIB en el GTV (total de 61.8 Gy) en 28 fracciones. Dosis de BRT: 21 Gy en 3 fracciones.<\/li>\n<li><strong>Terapia concomitante:<\/strong> Cisplatino semanal 40mg\/m\u00b2 + HT una vez por semana.<\/li>\n<\/ul>\n<\/div>\n<div style=\"background: #e8f5e9; padding: 20px; border-radius: 10px; border: 1px solid #2e7d32;\">\n<p><strong style=\"color: #1b5e20; font-size: 17px; display: block; margin-bottom: 10px;\">RESULTADOS Y CONCLUSIONES:<\/strong><\/p>\n<p style=\"font-size: 16px; font-weight: bold; margin: 0;\">SE ALCANZ\u00d3 UN 100% DE CONTROL LOCAL. No se observ\u00f3 ninguna toxicidad aguda o tard\u00eda de grado 3 a 4 relacionada con el tratamiento.<\/p>\n<p style=\"margin-top: 10px; font-style: italic;\">\u00abLa adici\u00f3n de la hipertermia local profunda a la quimiorradioterapia representa una nueva estrategia prometedora con excelente tolerancia.\u00bb<\/p>\n<\/div>\n<\/div>\n<\/section>\n<section style=\"margin-bottom: 50px; border: 1px solid #e1e8ed; border-radius: 15px; overflow: hidden; box-shadow: 0 5px 15px rgba(0,0,0,0.05);\">\n<div style=\"background: #b21f1f; color: #fff; padding: 20px;\">\n<h3 style=\"margin: 0; font-size: 19px;\">2. Estudio de Viabilidad (Caso-Control) \u2013 Hipertermia Local Profunda &#8211; Andaluc\u00eda, Espa\u00f1a<\/h3>\n<\/div>\n<div style=\"padding: 30px;\">\n<p><strong>Introducci\u00f3n:<\/strong> El primer ensayo cl\u00ednico en Espa\u00f1a que combina la hipertermia local profunda con tratamientos oncol\u00f3gicos est\u00e1ndar en el sistema p\u00fablico de salud.<\/p>\n<div style=\"display: grid; grid-template-columns: repeat(auto-fit, minmax(250px, 1fr)); gap: 20px; margin: 25px 0;\">\n<div style=\"background: #f0f4f8; padding: 15px; border-radius: 10px; border-top: 4px solid #1a2a6c;\"><strong>Dise\u00f1o del estudio:<\/strong> Estudio prospectivo de caso-control. 293 pacientes en total (97 en fase activa vs 196 controles). 9 localizaciones tumorales.<\/div>\n<div style=\"background: #f0f4f8; padding: 15px; border-radius: 10px; border-top: 4px solid #1a2a6c;\"><strong>Par\u00e1metros del tratamiento:<\/strong> 10 sesiones (2-3\/semana), duraci\u00f3n de 1 hora, 150W\u2013400W utilizando el <strong>dispositivo de hipertermia modulada HyDeep 600WM<\/strong>.<\/div>\n<\/div>\n<h4 style=\"color: #1a2a6c; border-bottom: 2px solid #b21f1f; display: inline-block; padding-bottom: 5px;\">Datos preliminares (subgrupo de 22 pacientes):<\/h4>\n<ul style=\"margin-top: 15px; font-size: 14px; column-count: 2;\">\n<li><strong>Glioblastoma (2c)<\/strong><\/li>\n<li><strong>Cabeza y Cuello (7c)<\/strong><\/li>\n<li><strong>Recto Preoperatorio (3c)<\/strong><\/li>\n<li><strong>C\u00e1ncer de Mama (3c)<\/strong><\/li>\n<li><strong>Pulm\u00f3n (NSCLC &#8211; 11c)<\/strong><\/li>\n<li><strong>Pr\u00f3stata (4c)<\/strong><\/li>\n<li><strong>Cuello Uterino y Met\u00e1stasis<\/strong><\/li>\n<\/ul>\n<div style=\"display: flex; flex-wrap: wrap; gap: 15px; margin: 25px 0;\">\n<div style=\"flex: 1; min-width: 200px; background: #fffde7; padding: 20px; border-radius: 10px; text-align: center; border: 1px solid #fbc02d;\"><span style=\"font-size: 28px; font-weight: 800; display: block;\">81.2%<\/span><br \/>\n<strong>ALTA TOLERANCIA<\/strong><br \/>\n<small>Pacientes satisfechos o muy satisfechos<\/small><\/div>\n<div style=\"flex: 1; min-width: 200px; background: #f1f8e9; padding: 20px; border-radius: 10px; text-align: center; border: 1px solid #7cb342;\"><span style=\"font-size: 28px; font-weight: 800; display: block;\">66.6%<\/span><br \/>\n<strong>TOXICIDAD CERO<\/strong><br \/>\n<small>No se reportaron efectos adversos<\/small><\/div>\n<\/div>\n<p style=\"background: #f4f7f9; padding: 15px; border-radius: 8px; border-left: 4px solid #1a2a6c;\"><strong>CONCLUSI\u00d3N:<\/strong> La hipertermia local profunda es viable en la atenci\u00f3n hospitalaria p\u00fablica de rutina sin recursos extraordinarios. La selecci\u00f3n adecuada de los pacientes garantiza una toxicidad m\u00ednima (Grado 1).<\/p>\n<div style=\"text-align: center; margin-top: 30px;\"><a style=\"display: inline-block; background: #b21f1f; color: #fff; padding: 14px 30px; text-decoration: none; border-radius: 5px; font-weight: 800; text-transform: uppercase; box-shadow: 0 4px 10px rgba(178,31,31,0.3);\" href=\"http:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/Protocolo-del-ensayo-MAG-HIP-2013-01-11-EN.pdf\">Descargar Protocolo Completo del Estudio (PDF)<\/a><\/div>\n<\/div>\n<\/section>\n<div style=\"margin-top: 40px;\">\n<h3 style=\"text-align: center; color: #1a2a6c; text-transform: uppercase; letter-spacing: 1px;\">P\u00f3steres Cient\u00edficos y Documentaci\u00f3n ESHO<\/h3>\n<div id='gallery-1' class='gallery galleryid-6662 gallery-columns-1 gallery-size-full'><figure class='gallery-item'>\n\t\t\t<div class='gallery-icon portrait'>\n\t\t\t\t<a href=\"https:\/\/andromedichyperthermia.com\/es\/estudio-hipertermia-andromedic\/preliminary-results-of-chemoradiation-plus-hyperthermia-and-high-dose-rate-brachytherapy-for-locally-advanced-cervical-carcinoma-2\/\"><img loading=\"lazy\" decoding=\"async\" width=\"590\" height=\"837\" src=\"https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/Preliminary-results-of-chemoradiation-plus-hyperthermia-and-high-dose-rate-brachytherapy-for-locally-advanced-cervical-carcinoma.jpg\" class=\"attachment-full size-full\" alt=\"Preliminary results of chemoradiation plus Andromedic hyperthermia and high dose rate brachytherapy for locally advanced cervical carcinoma\" aria-describedby=\"gallery-1-7006\" srcset=\"https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/Preliminary-results-of-chemoradiation-plus-hyperthermia-and-high-dose-rate-brachytherapy-for-locally-advanced-cervical-carcinoma.jpg 590w, https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/Preliminary-results-of-chemoradiation-plus-hyperthermia-and-high-dose-rate-brachytherapy-for-locally-advanced-cervical-carcinoma-211x300.jpg 211w\" sizes=\"auto, (max-width: 590px) 100vw, 590px\" title=\"\"><\/a>\n\t\t\t<\/div>\n\t\t\t\t<figcaption class='wp-caption-text gallery-caption' id='gallery-1-7006'>\n\t\t\t\tPreliminary results of chemoradiation plus Andromedic hyperthermia and high dose rate brachytherapy for locally advanced cervical carcinoma\n\t\t\t\t<\/figcaption><\/figure><figure class='gallery-item'>\n\t\t\t<div class='gallery-icon portrait'>\n\t\t\t\t<a href=\"https:\/\/andromedichyperthermia.com\/es\/quasi-feasibility-studycase-control-asscoaiting-deep-local-hyperthermia-treatment-with-standard-cancer-treatments-and-describing-patterns-of-response-b\/\"><img loading=\"lazy\" decoding=\"async\" width=\"569\" height=\"831\" src=\"https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/Quasi-feasibility-studycase-control-asscoaiting-deep-local-hyperthermia-treatment-with-standard-cancer-treatments-and-describing-patterns-of-response-B.jpg\" class=\"attachment-full size-full\" alt=\"Quasi feasibility study(case control) asscoaiting deep local hyperthermia treatment with standard cancer treatments and describing patterns of response ESHO\" aria-describedby=\"gallery-1-13989\" srcset=\"https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/Quasi-feasibility-studycase-control-asscoaiting-deep-local-hyperthermia-treatment-with-standard-cancer-treatments-and-describing-patterns-of-response-B.jpg 569w, https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/Quasi-feasibility-studycase-control-asscoaiting-deep-local-hyperthermia-treatment-with-standard-cancer-treatments-and-describing-patterns-of-response-B-205x300.jpg 205w\" sizes=\"auto, (max-width: 569px) 100vw, 569px\" title=\"\"><\/a>\n\t\t\t<\/div>\n\t\t\t\t<figcaption class='wp-caption-text gallery-caption' id='gallery-1-13989'>\n\t\t\t\tQuasi feasibility study(case control) asscoaiting deep local hyperthermia treatment with standard cancer treatments and describing patterns of response ESHO\n\t\t\t\t<\/figcaption><\/figure><figure class='gallery-item'>\n\t\t\t<div class='gallery-icon portrait'>\n\t\t\t\t<a href=\"https:\/\/andromedichyperthermia.com\/es\/quasi-feasibility-studycase-control-asscoaiting-deep-local-hyperthermia-treatment-with-standard-cancer-treatments-and-describing-patterns-of-response-2-2\/\"><img loading=\"lazy\" decoding=\"async\" width=\"568\" height=\"826\" src=\"https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/Quasi-feasibility-studycase-control-asscoaiting-deep-local-hyperthermia-treatment-with-standard-cancer-treatments-and-describing-patterns-of-response.jpg\" class=\"attachment-full size-full\" alt=\"\" aria-describedby=\"gallery-1-10013\" srcset=\"https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/Quasi-feasibility-studycase-control-asscoaiting-deep-local-hyperthermia-treatment-with-standard-cancer-treatments-and-describing-patterns-of-response.jpg 568w, https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/Quasi-feasibility-studycase-control-asscoaiting-deep-local-hyperthermia-treatment-with-standard-cancer-treatments-and-describing-patterns-of-response-206x300.jpg 206w\" sizes=\"auto, (max-width: 568px) 100vw, 568px\" title=\"\"><\/a>\n\t\t\t<\/div>\n\t\t\t\t<figcaption class='wp-caption-text gallery-caption' id='gallery-1-10013'>\n\t\t\t\tQuasi feasibility study(case control) associating deep local hyperthermia HyDeep 600WM treatment with standard cancer treatments and describing patterns of response\n\t\t\t\t<\/figcaption><\/figure>\n\t\t<\/div>\n\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Sociedad Europea de Oncolog\u00eda Hipert\u00e9rmica: ESHO 2014 Intervenci\u00f3n Andromedic \u2013 Dr. Salvatore Conte En el congreso ESHO 2014, el Dr. Salvatore Conte anunci\u00f3 un hito importante para el equipo de hipertermia de Andromedic: la fabricaci\u00f3n y entrega exitosa de 25 dispositivos de hipertermia local profunda HyDeep 600WM en solo 18 meses, con 40 unidades adicionales&hellip;<\/p>\n","protected":false},"author":1,"featured_media":17357,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"template-gutentor-full-width.php","meta":{"footnotes":""},"class_list":["post-6662","page","type-page","status-publish","has-post-thumbnail","hentry"],"_links":{"self":[{"href":"https:\/\/andromedichyperthermia.com\/es\/wp-json\/wp\/v2\/pages\/6662","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/andromedichyperthermia.com\/es\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/andromedichyperthermia.com\/es\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/andromedichyperthermia.com\/es\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/andromedichyperthermia.com\/es\/wp-json\/wp\/v2\/comments?post=6662"}],"version-history":[{"count":0,"href":"https:\/\/andromedichyperthermia.com\/es\/wp-json\/wp\/v2\/pages\/6662\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/andromedichyperthermia.com\/es\/wp-json\/wp\/v2\/media\/17357"}],"wp:attachment":[{"href":"https:\/\/andromedichyperthermia.com\/es\/wp-json\/wp\/v2\/media?parent=6662"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}